27/05/2025 09:43
EQS-Adhoc: Pentixapharm Holding AG: Pentixapharm outlines new clinical development strategy
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd pEQSAdhoc: Pentixapharm Holding AG / Key words: Studybr/ Pentixapharm Holding AG: Pentixapharm outlines new clinical development strategy br/br/ 27May2025 / 09:43 CET/CESTbr/ Disclosure of an inside information... Lire...
25/04/2025 15:39
EQS-News: Pentixapharm to Present First-in-Class Glycan-Dependent CD24 Antibody GT-008 for Solid Tumors at AACR 2025
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: Pentixapharm Holding AG / Key words: Conference/Scientific publication br/ Pentixapharm to Present FirstinClass GlycanDependent CD24 Antibody GT008 for Solid Tumors at AACR 2025... Lire...
24/04/2025 14:00
EQS-News: Pentixapharm Signs Contract Manufacturing Agreement for Yttrium-90-based PentixaTher with Eckert & Ziegler SE
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: Pentixapharm Holding AG / Key words: Contract br/ Pentixapharm Signs Contract Manufacturing Agreement for Yttrium90based PentixaTher with Eckert & Ziegler SE... Lire...
15/04/2025 08:17
EQS-News: Pentixapharm Holding AG Releases Financial Results for 2024 and Announces Guidance for the 2025 Financial Year
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: Pentixapharm Holding AG / Key words: Annual Report/Annual Results br/ Pentixapharm Holding AG Releases Financial Results for 2024 and Announces Guidance for the 2025 Financial Year... Lire...
03/03/2025 14:38
EQS-News: Changes in the Supervisory Board and Management Board of Pentixapharm Holding AG
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: Pentixapharm Holding AG / Key words: Personnel br/ Changes in the Supervisory Board and Management Board of Pentixapharm Holding AG br/br/ 03.03.2025 / 14:38... Lire...
13/02/2025 14:10
EQS-News: First-In-Human Data about the Treatment of Muscle-Invasive Bladder Cancer with Pentixapharm’s Lu177-PentixaTher to be Presented at ASCO-GU 2025
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: Pentixapharm Holding AG / Key words: Conference br/ FirstInHuman Data about the Treatment of MuscleInvasive Bladder Cancer with Pentixapharm’s Lu177PentixaTher to be Presented... Lire...
24/01/2025 17:00
EQS-Adhoc: Pentixapharm Holding AG Closes the 2024 Financial Year With a Loss of EUR 14 Million, Including Risk Provisions for Myelo Amounting to EUR 7 Million
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd pEQSAdhoc: Pentixapharm Holding AG / Key words: Preliminary Resultsbr/ Pentixapharm Holding AG Closes the 2024 Financial Year With a Loss of EUR 14 Million, Including Risk Provisions for Myelo Amounting to EUR 7... Lire...
07/01/2025 10:30
EQS-News: Pentixapharm Receives EUR 6.77 Million for Intangible Assets Formerly Developed by Glycotope
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: Pentixapharm Holding AG / Key words: Agreement br/ Pentixapharm Receives EUR 6.77 Million for Intangible Assets Formerly Developed by Glycotope br/br/ 07.01.2025 / 10:30... Lire...
21/11/2024 13:41
Original-Research: Pentixapharm Holding AG (von BankM AG): Kaufen
html xmlns=http://www.w3.org/1999/xhtmlbodytable border=trtd p OriginalResearch: Pentixapharm Holding AG von BankM AG br/br/ 21.11.2024 / 13:40 CET/CESTbr/ Veröffentlichung einer Research, übermittelt durch EQS News ein Service der EQS Group AG.br/ Für den Inhalt der... Lire...